1887

Abstract

Nine overlapping peptides (20 amino acid) covering the entire sequence of early antigen E7 of human papillomavirus type 16 (HPV-16) were synthesized and tested as antigens with human sera in ELISA. Five of these peptides (no. 1 to 5 counting from the N terminus of the E7 protein) reacted with a pool of sera from HPV-16-infected individuals (as determined by molecular hybridization with their biopsy specimens); one (no. 5) was also reactive with pools of HPV-18- and HPV-6- or 11-infected individuals. Sera from 24 patients with cervical intraepithelial neoplasia (CIN) and from 29 invasive cervical carcinoma (INCA) patients were tested for the presence of antibodies reactive with peptides, no. 1 to 4 covering amino acids 1 to 50 and with peptide no. 5 covering amino acids 41 to 60. Only one of the sera from CIN patients was reactive with peptides no. 1 (amino acids 1 to 20) and no. 4 (amino acids 31 to 50). However, the majority of these sera reacted with peptide no. 5. The occurrence of this antibody was only slightly less frequent in sera from healthy subjects compared to CIN patients. On the other hand, sera from the INCA patients were reactive with the peptides no. 1 to 3 more frequently than the sera from matched control subjects. Positive reactions of sera from INCA patients were most frequently seen with no. 2; 24% of these sera but only 7% of the controls were reactive with no. 2 peptide. The present data suggest that no. 1 to 3 are HPV-16-specific, whereas no. 5 is broadly cross-reactive.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-11-2719
1990-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/11/JV0710112719.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-11-2719&mimeType=html&fmt=ahah

References

  1. Anisimová E., Barták P., Vlček V., Hirsch I., Břicháček B., Vonka V. 1990; Presence and type specificity of papillomavirus antibodies demonstrable by immunoelectron microscopy tests in samples from patients with warts. Journal of General Virology 71:419–422
    [Google Scholar]
  2. Břicháček B., Hirsch I., Sibl O., Vilikusová E., Vonka V. 1983; Association of some supraglottic laryngeal carcinomas with EB virus. International Journal of Cancer 32:193–197
    [Google Scholar]
  3. Dillner J., Dillner L., Robb J., Willems J., Jones I., Lancaster W., Smith R., Lerner R. 1989; A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences, U.S.A 86:3838–3841
    [Google Scholar]
  4. Goldsborough M. D., Disilvestre D., Temple G. F., Lorincz A. T. 1989; Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 171:306–311
    [Google Scholar]
  5. Jochmus-Kudielka I., Schneider A., Braun R., Kimming R., Koldovsky U., Schneweis K. E., Seedorf K., Gissmann L. 1989; Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. Journal of the National Cancer Institute 82:1698–1703
    [Google Scholar]
  6. Krchňák V., Vágner J., Flegel M., Mach O. 1987; Continuous-flow solid-phase peptide synthesis. Tetrahedron Letters 28:4469–4472
    [Google Scholar]
  7. Krchňák V., Vágner J., Šafář P., Lebl M. 1988; Non-invasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collection of Czechoslovak Chemical Communications 53:2542–2548
    [Google Scholar]
  8. Krchňák V., Mach O., Malý A. 1989a; Computer prediction of β-cell determinants from the protein amino acid sequence based on incidence of β-turns. Methods in Enzymology 178:586–611
    [Google Scholar]
  9. Krchňák V., Vágner J., Mach O. 1989b; Multiple continuous flow solid-phase peptide synthesis.The synthesis of an HIV antigenic peptide and its omission analogues. International Journal of Peptide and Protein Research 33:209–213
    [Google Scholar]
  10. Phelps W. C., Yee C. L., Munger K., Howley P. M. 1989; The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1 A. Cell 53:539–547
    [Google Scholar]
  11. Rigby P. W. J., Dieckmann M., Rhodes C., Berg P. 1977; Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. Journal of Molecular Biology 113:237–251
    [Google Scholar]
  12. Schwarz E., Freese U. K., Gissmann L., Maeyer B., Roggenbuck A., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature; London: 314111–113
    [Google Scholar]
  13. Smotkin D., Wettstein F. O. 1986; Transcription of human papillomavirus type 16 early genes in cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proceedings of the National Academy of Sciences, U.S.A 83:4680–4684
    [Google Scholar]
  14. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. 1988; Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7:1815–1820
    [Google Scholar]
  15. Suchánková A., Ritter O., Hirsch I., Krchňák V., Vágner J., Kaloš Z., Hamšíková E., Břicháček B., Vonka V. 1990; Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera. Acta virologica in press
    [Google Scholar]
  16. Watanabe S., Kanda T., Yoshiike K. 1989; Human papillomavirus type 16 transformation of primary-human embryonic fibroblasts requires expression of open reading frames E6 & E7. Journal of Virology 63:965–969
    [Google Scholar]
  17. zur Hausen H. 1989; Papillomaviruses as carcinomaviruses. In Advances in Viral Oncology 8 pp. 1–26 Klein G. Edited by New York: Raven Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-11-2719
Loading
/content/journal/jgv/10.1099/0022-1317-71-11-2719
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error